ANNA BARRICKMAN: Open Payments
NPI 1891217527 · SHELBYVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 31 payments from 17 companies in 2025. Trend: 2023 $470 · 2024 $598 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $210 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| PFIZER INC. | 3 | $61 |
| ABBVIE INC. | 2 | $43 |
| Lilly USA, LLC | 2 | $42 |
| Corcept Therapeutics | 2 | $38 |
| ABIOMED | 1 | $34 |
| Abbott Laboratories | 2 | $33 |
| Exact Sciences Corporation | 2 | $28 |
| Medtronic, Inc. | 1 | $25 |
Products named: Ozempic, CAPLYTA, Wegovy, VRAYLAR, MOUNJARO, PREVNAR 20, Korlym, FREESTYLE LIBRE 3.
Industry payments across KY — which companies pay providers there.
